HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Interim estimates of 2013/14 influenza clinical severity and vaccine effectiveness in the prevention of laboratory-confirmed influenza-related hospitalisation, Canada, February 2014.

Abstract
During the 2013/14 influenza season in Canada, 631 of 654 hospitalisations for laboratory-confirmed influenza enrolled in sentinel hospitals were due to Influenza A. Of the 375 with known subtype, influenza A(H1N1) accounted for 357. Interim unmatched vaccine effectiveness adjusted for age and presence of one or more medical comorbidities was determined by test-negative case-control design to be 58.5% (90% confidence interval (CI): 43.9-69.3%) overall and 57.9% (90% CI: 37.7-71.5) for confirmed influenza A(H1N1).
AuthorsSa McNeil, V Shinde, M Andrew, Tf Hatchette, J Leblanc, A Ambrose, G Boivin, Wr Bowie, F Diaz-Mitoma, M Elsherif, K Green, F Haguinet, S Halperin, B Ibarguchi, K Katz, J Langley, P Lagace-Wiens, B Light, M Loeb, J McElhaney, D Mackinnon-Cameron, Ae McCarthy, M Poirier, J Powis, D Richardson, M Semret, S Smith, D Smyth, G Stiver, S Trottier, L Valiquette, D Webster, L Ye, A McGeer, Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Serious Outcomes Surveillance Network, Toronto Invasive Bacterial Diseases Network (TIBDN)
JournalEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin (Euro Surveill) Vol. 19 Issue 9 (Mar 06 2014) ISSN: 1560-7917 [Electronic] Sweden
PMID24626207 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Influenza Vaccines
Topics
  • Adolescent
  • Adult
  • Aged
  • Canada (epidemiology)
  • Case-Control Studies
  • Child
  • Child, Preschool
  • Female
  • Hospitalization (statistics & numerical data)
  • Humans
  • Influenza A Virus, H1N1 Subtype (immunology, isolation & purification)
  • Influenza Vaccines (administration & dosage, immunology)
  • Influenza, Human (epidemiology, prevention & control, virology)
  • Laboratories
  • Male
  • Middle Aged
  • Outcome Assessment, Health Care
  • Seasons
  • Sentinel Surveillance
  • Severity of Illness Index
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: